Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen van Besien

Showing results (171-180 of 241) with videos related to

Pageof 25
Sort By:
Leukemia & Lymphoma|October 6, 2010
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive diseasePeter H O'Donnell, Andrew S Artz, Samir D Undevia, et al.
Transfusion|December 2, 2017
Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experienceRonit Reich-Slotky, Melissa M Cushing, Yen-Michael S Hsu, et al.
Bone Marrow Transplantation|June 11, 2020
Cord blood transplants supported by unrelated donor CD34<sup>+</sup> progenitor cellsAlexandra Gomez-Arteaga, Nina Orfali, Danielle Guarneri, et al.
Leukemia & Lymphoma|June 12, 2010
Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplantLucy A Godley, Uchenna O Njiaju, Margaret Green, et al.
Bone Marrow Transplantation|April 12, 2023
Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD)Alexandra Gomez-Arteaga, Nina Orfali, Michelle Pasciolla, et al.
Transplantation and Cellular Therapy|February 4, 2023
Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell TransplantationMohammad Alhomoud, Nora Chokr, Alexandra Gomez-Arteaga, et al.
Transplantation and Cellular Therapy|September 7, 2024
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors)Nima Ghalehsari, Franco Castillo Tokumori, Zhengming Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2017
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older AdultsStephanie B Tsai, Joanna Rhodes, Hongtao Liu, et al.
Blood|July 16, 2008
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host diseaseMary E D Flowers, Jane F Apperley, Koen van Besien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndromeKoen van Besien, A Artz, S Smith, et al.
Pageof 25

Showing results (171-180 of 241) with videos related to

Sort By:
Pageof 25
Leukemia & Lymphoma|October 6, 2010
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive diseasePeter H O'Donnell, Andrew S Artz, Samir D Undevia, et al.
Transfusion|December 2, 2017
Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experienceRonit Reich-Slotky, Melissa M Cushing, Yen-Michael S Hsu, et al.
Bone Marrow Transplantation|June 11, 2020
Cord blood transplants supported by unrelated donor CD34<sup>+</sup> progenitor cellsAlexandra Gomez-Arteaga, Nina Orfali, Danielle Guarneri, et al.
Leukemia & Lymphoma|June 12, 2010
Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplantLucy A Godley, Uchenna O Njiaju, Margaret Green, et al.
Bone Marrow Transplantation|April 12, 2023
Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD)Alexandra Gomez-Arteaga, Nina Orfali, Michelle Pasciolla, et al.
Transplantation and Cellular Therapy|February 4, 2023
Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell TransplantationMohammad Alhomoud, Nora Chokr, Alexandra Gomez-Arteaga, et al.
Transplantation and Cellular Therapy|September 7, 2024
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors)Nima Ghalehsari, Franco Castillo Tokumori, Zhengming Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2017
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older AdultsStephanie B Tsai, Joanna Rhodes, Hongtao Liu, et al.
Blood|July 16, 2008
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host diseaseMary E D Flowers, Jane F Apperley, Koen van Besien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndromeKoen van Besien, A Artz, S Smith, et al.
Pageof 25